Rheumatic mitral valve stenosis is associated with impaired flow-mediated dilatation

International Journal of Cardiology

Volumn 125, Issue 3, 2008, Pages 410-412

  Tekin, Abdullah ^a   Tekin, Göknur ^a   Sezgin, Alpay Turan ^a   Hücran, Cem ^a   Kizilkiliç, Osman ^a   Erol, Tansel ^a   Müderrisoǧlu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Flow mediated dilatation; Mitral stenosis; Vascular endothelium

Indexed keywords

ADULT; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; RHEUMATIC FEVER; VASCULAR ENDOTHELIUM;

ADULT; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MITRAL VALVE STENOSIS; RHEUMATIC HEART DISEASE;

EID: 40949096943     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.048     Document Type: Article

References (15)

1. Rowe J.C., Bland E.F., Sprague H.B., and White P.D. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med 52 (1960) 741-749
2. Roberts S., Kosanke S., Terrence Dunn S., Jankelow D., Duran C.M., and Cunningham M.W. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 183 (2001) 507-511
3. Yetkin E., Erbay A.R., Turhan H., et al. Decreased platelet activation and endothelial dysfunction after percutaneous mitral balloon valvuloplasty. Int J Cardiol 91 (2003) 221-225
4. Yetkin E., Erbay A.R., Ileri M., et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 88 (2001) 1209-1211
5. Yetkin E., Erbay A.R., Turhan H., et al. Changes in plasma levels of adhesion molecules after percutaneous mitral balloon valvuloplasty. Cardiovasc Pathol 13 (2004) 103-108
6. Chen M.C., Chang H.W., Juang S.S., et al. Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis. Chest 125 (2004) 1213-1217
7. Chen M.C., Wu C.J., Yip H.K., et al. Increased circulating endothelin-1 in rheumatic mitral stenosis: irrelevance to left atrial and pulmonary artery pressures. Chest 125 (2004) 390-396
8. Yamamoto K., Ikeda U., Mito H., Fujikawa H., Sekiguchi H., and Shimada K. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 89 (1994) 2093-2098
9. Kinoshita O., Yoshimi H., Nagata S., et al. Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis. Br Heart J 69 (1993) 322-326
10. Williams M.R., Westerman R.A., Kingwell B.A., et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 86 (2001) 5389-5395
11. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
12. Chen M.C., Chang H.W., Juang S.S., Yip H.K., and Wu C.J. Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest 126 (2004) 54-58
13. Chang C.J., Hsu L.A., Chiang C.W., et al. Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-alpha and interleukin-6 in mitral stenosis with heart failure. Am J Cardiol 91 (2003) 1018-1020
14. Witte D.R., Broekmans W.M., Kardinaal A.F., et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis 170 (2003) 147-153
15. Berger R., Stanek B., Hulsmann M., et al. Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure. Circulation 103 (2001) 981-986